These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10827245)

  • 41. Issues in the design of the fluconazole prophylaxis trials in patients undergoing hematopoietic stem cell transplantation.
    Marr KA
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S170-5. PubMed ID: 15546113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful treatment of Trichosporon mucoides infection with fluconazole in a heart and kidney transplant recipient.
    Nettles RE; Nichols LS; Bell-McGuinn K; Pipeling MR; Scheel PJ; Merz WG
    Clin Infect Dis; 2003 Feb; 36(4):E63-6. PubMed ID: 12567323
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of systemic mycoses in patients who are not neutropenic: should we do it? Can we do it?
    Graybill JR
    Braz J Infect Dis; 2000 Jun; 4(3):108-12. PubMed ID: 10934492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antifungal prophylaxis in neutropenic patients].
    Cornely OA; Ullmann AJ; Karthaus M
    Wien Med Wochenschr; 2001; 151(3-4):73-9. PubMed ID: 11789422
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variation in antifungal prophylaxis strategies in lung transplantation.
    Husain S; Zaldonis D; Kusne S; Kwak EJ; Paterson DL; McCurry KR
    Transpl Infect Dis; 2006 Dec; 8(4):213-8. PubMed ID: 17116134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antifungal prophylaxis among allogeneic hematopoietic stem cell transplant recipients: current issues and new agents.
    Strasfeld L; Weinstock DM
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):457-68. PubMed ID: 16771622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fungal prophylaxis with AmBisome in liver and bone marrow transplant recipients: results of two randomized double-blind studies.
    Tollemar J; Höckerstedt K; Ericzon BG; Sundberg B; Ringdén O
    Transplant Proc; 1994 Jun; 26(3):1833. PubMed ID: 8030161
    [No Abstract]   [Full Text] [Related]  

  • 48. Preventing intra-abdominal candidiasis in surgical patients.
    Rex JH; Sobel JD
    Crit Care Med; 1999 Jun; 27(6):1033-4. PubMed ID: 10397189
    [No Abstract]   [Full Text] [Related]  

  • 49. Systemic antifungal prophylaxis for very low birthweight infants: a systematic review.
    Clerihew L; Austin N; McGuire W
    Arch Dis Child Fetal Neonatal Ed; 2008 May; 93(3):F198-200. PubMed ID: 17768155
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial.
    Marr KA; Seidel K; Slavin MA; Bowden RA; Schoch HG; Flowers ME; Corey L; Boeckh M
    Blood; 2000 Sep; 96(6):2055-61. PubMed ID: 10979947
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prophylaxis of candidosis in case of secondary immunodeficiency].
    Kolbin AS; Ivanov DO; Shabalov NP; Klimko NN; Karpov OI
    Antibiot Khimioter; 2003; 48(4):35-9. PubMed ID: 13677136
    [No Abstract]   [Full Text] [Related]  

  • 52. [Fungal infections in the neonate - diagnosis, treatment and prevention].
    Pawlik D; Lauterbach R
    Med Wieku Rozwoj; 2008; 12(4 Pt 1):885-90. PubMed ID: 19471062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prophylactic fluconazole and marrow transplantation.
    Scholten SL; Nettleman MD; Sarrazin EF
    N Engl J Med; 1992 Aug; 327(9):644-5; author reply 645. PubMed ID: 1640963
    [No Abstract]   [Full Text] [Related]  

  • 54. Empirical use of fluconazole in critically ill patients: good study, but what was the hold-up?
    Lee DH
    Ann Intern Med; 2009 Jan; 150(1):59; author reply 59-60. PubMed ID: 19124827
    [No Abstract]   [Full Text] [Related]  

  • 55. Empirical use of fluconazole in critically ill patients: good study, but what was the hold-up?
    Shelburne SA
    Ann Intern Med; 2009 Jan; 150(1):58-9; author reply 59-60. PubMed ID: 19124825
    [No Abstract]   [Full Text] [Related]  

  • 56. Antifungal management practices in liver transplant recipients.
    Singh N; Wagener MM; Cacciarelli TV; Levitsky J
    Am J Transplant; 2008 Feb; 8(2):426-31. PubMed ID: 18190655
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased cyclosporine levels as a result of simultaneous fluconazole and cyclosporine therapy in renal transplant recipients: a double-blind, randomized pharmacokinetic and safety study.
    Canafax DM; Graves NM; Hilligoss DM; Carleton BC; Gardner MJ; Matas AJ
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1041-2. PubMed ID: 1989149
    [No Abstract]   [Full Text] [Related]  

  • 58. Prophylaxis with oral fluconazole and an oral solution of amphotericin B in liver transplant patients.
    Fortun J; Martin-Davila P; de Vicente E; Nuño J; Alvarez ME; Sanchez-Sousa A; Barcena R; Lopez-San roman A; Candelas A; Honrubia A; Navas E; Moreno S
    Transplant Proc; 2002 Feb; 34(1):80-1. PubMed ID: 11959195
    [No Abstract]   [Full Text] [Related]  

  • 59. Fluconazole in transplant recipients: options and limitations.
    Strahilevitz J; Sugar AM; Engelhard D
    Transpl Infect Dis; 2000 Jun; 2(2):62-71. PubMed ID: 11429014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fungal infections.
    Am J Transplant; 2004 Nov; 4 Suppl 10():110-34. PubMed ID: 15504225
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.